BYU RB LJ Martin out of Pop-Tarts Bowl due to surgery


Published on: Dec 24, 2025 06:24 am IST

Running back LJ Martin has undergone a recent surgery and won’t be available.

The junior running back, mulling a return to BYU or a declaration for the ⁠2026 NFL Draft following a 1,305-yard ⁠rushing season, would be equally well served by the earlier surgery ⁠date in either case, per Sitake.

“I think everybody kind of knows that there was a small window for ‍him to ‌get this surgery done,” Sitake said. “His decision is going to be whether he comes back ​and plays his senior year, or whether he goes to the NFL. So, with that in mind, there’s a small window where he could have the surgery done now, or if he had to wait, then it would prolong it too long, where it wouldn’t be beneficial for him either way.”

Martin averaged 5.5 yards per carry and totaled 12 touchdowns ​on ⁠the ground over 13 games in 2025, his most prolific as a Cougar. He added 36 ⁠receptions for 255 yards for the 11-2 Cougars.

Sitake didn’t reveal the nature ‌of the surgery, but Martin was previously limited after suffering an apparent shoulder injury against Iowa State on Oct. 25. Martin had just ​five carries before exiting, then managed just 10 carries in the following week vs. Texas Tech, his two least productive games of ‍the season.

No. 12 BYU is ‍expected to ⁠lean on a mix of players to replace Martin against the No. 22 Yellow Jackets .

“We’re going to the rely on depth of the running back room, but for the most part, we should have a lot of guys,” Sitake said.

Field Level ‌Media

This article was generated from an automated news agency feed without modifications to text.

Stay updated with the latest sports news, including latest headlines and updates from the Durand Cup Final Live. Catch all the action from tennis Grand Slam tournaments, follow your favourite football teams and players with the latest match results, and get the latest on international hockey tournaments and series.


Related Posts

Why Mike Vrabel, Dianna Russini were ‘holding hands’ at a Sedona hotel. Truth behind cheating controversy

New England Patriots head coach Mike Vrabel and NFL insider Dianna Russini have both pushed back strongly against speculation around viral photos taken in Sedona, Arizona. This comes after PageSix…

Candidates: Divya beats Anna, jumps into joint lead; Pragg loses

Bengaluru: Eight rounds into the Candidates tournament and 20-year-old Javokhir Sindarov is unbeaten, lounging comfortably with a two-point lead. Fabiano Caruana, who was in hot pursuit, tripped up in Round…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Raaka: Allu Arjun goes bald, sports animal claws in jaw-dropping first look at Atlee’s AA22 X A6; fans stunned

  • By admin
  • April 8, 2026
  • 0 views
Raaka: Allu Arjun goes bald, sports animal claws in jaw-dropping first look at Atlee’s AA22 X A6; fans stunned

Deepika Padukone hits back at Dhurandhar 2 ‘silent treatment’ chatter, says she watched it ‘before any of you did’: ‘Now who is the joke on?’ | Bollywood News

  • By admin
  • April 8, 2026
  • 0 views
Deepika Padukone hits back at Dhurandhar 2 ‘silent treatment’ chatter, says she watched it ‘before any of you did’: ‘Now who is the joke on?’ | Bollywood News

US calls Iran ceasefire a ‘victory’, says Operation Epic Fury met goals early | World News

  • By admin
  • April 8, 2026
  • 1 views
US calls Iran ceasefire a ‘victory’, says Operation Epic Fury met goals early | World News

Why Mike Vrabel, Dianna Russini were ‘holding hands’ at a Sedona hotel. Truth behind cheating controversy

  • By admin
  • April 8, 2026
  • 3 views
Why Mike Vrabel, Dianna Russini were ‘holding hands’ at a Sedona hotel. Truth behind cheating controversy

Korean Stocks, Won Surge After Iran Ceasefire Brings Relief

  • By admin
  • April 8, 2026
  • 2 views
Korean Stocks, Won Surge After Iran Ceasefire Brings Relief

Novo Nordisk’s Wegovy pill launch draws new wave of patients to GLP-1s

  • By admin
  • April 8, 2026
  • 4 views
Novo Nordisk’s Wegovy pill launch draws new wave of patients to GLP-1s